Cargando…

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder

Objective: Evidence has shown that brain-derived neurotrophic factor (BDNF) is associated with anhedonia symptoms in major depressive disorder (MDD) patients, while the rapid antianhedonic effects of ketamine may occur independently of depressive symptoms. To our knowledge, the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Wei, Gu, Limei, Zhou, Yanling, Wang, Chengyu, Lan, Xiaofeng, Zhang, Bin, Li, Zezhi, Ning, Yuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227912/ https://www.ncbi.nlm.nih.gov/pubmed/36173064 http://dx.doi.org/10.2174/1570159X20666220927085706

Ejemplares similares

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Cognitive Function Mediates the Anti-suicide Effect of Repeated Intravenous Ketamine in Adult Patients With Suicidal Ideation
por: Zhou, Yanling, et al.
Publicado: (2022)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

The functional connectivity of the middle frontal cortex predicts ketamine’s outcome in major depressive disorder
por: Zhang, Fan, et al.
Publicado: (2022)

Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine
por: Zhou, Yanling, et al.
Publicado: (2021)

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study
por: Ray, Jason C., et al.
Publicado: (2022)

Ketamine Alleviates Postoperative Depression-Like Symptoms in Susceptible Mice: The Role of BDNF-TrkB Signaling
por: Li, Shan, et al.
Publicado: (2020)

Baseline patterns of resting functional connectivity within posterior default-mode intranetwork associated with remission to antidepressants in major depressive disorder
por: Ye, Yanxiang, et al.
Publicado: (2022)

Antianhedonic and Antidepressant Effects of Affron(®), a Standardized Saffron (Crocus Sativus L.) Extract
por: Orio, Laura, et al.
Publicado: (2020)

Pre-treatment Pain Symptoms Influence Antidepressant Response to Ketamine in Depressive Patients
por: Lan, Xiaofeng, et al.
Publicado: (2022)

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
por: Lan, Xiaofeng, et al.
Publicado: (2023)

Baseline blood pressure does not modify the effect of intravenous thrombolysis in successfully revascularized patients
por: Xiaoxi, Zhang, et al.
Publicado: (2022)

BDNF Val66Met Genetic Polymorphism Results in Poor Recovery Following Repeated Mild Traumatic Brain Injury in a Mouse Model and Treatment With AAV-BDNF Improves Outcomes
por: Giarratana, Anna O., et al.
Publicado: (2019)

Ketamine Rescues Hippocampal Reelin Expression and Synaptic Markers in the Repeated-Corticosterone Chronic Stress Paradigm
por: Johnston, Jenessa N., et al.
Publicado: (2020)

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020)

CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration
por: Poulia, Nafsika, et al.
Publicado: (2021)

Intravenous Thrombolysis May Not Improve Clinical Outcome of Acute Ischemic Stroke Patients Without a Baseline Vessel Occlusion
por: Tian, Huiqiao, et al.
Publicado: (2018)

Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease
por: Yi, Xu, et al.
Publicado: (2021)

Ketamine and Its Emergence in the Field of Neurology
por: Rueda Carrillo, Luis, et al.
Publicado: (2022)

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study
por: Huang, Xing-Bing, et al.
Publicado: (2020)

BDNF Release Is Required for the Behavioral Actions of Ketamine
por: Lepack, Ashley E., et al.
Publicado: (2014)

Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine
por: Ho, Ming-Fen, et al.
Publicado: (2019)

The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression—The Results From the KEOpS Study
por: Brunelin, Jerome, et al.
Publicado: (2020)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Combination of Dexmedetomidine and Ketamine for Magnetic Resonance Imaging Sedation
por: Kim, Joong-Goo, et al.
Publicado: (2019)

The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
por: Jin, Yang, et al.
Publicado: (2019)

Negative relationship between brain-derived neurotrophic factor (BDNF) and attention: A possible elevation in BDNF level among high-altitude migrants
por: Fan, Jing, et al.
Publicado: (2023)

Effects of Ketamine on Postoperative Pain After Remifentanil-Based Anesthesia for Major and Minor Surgery in Adults: A Systematic Review and Meta-Analysis
por: García-Henares, Juan F., et al.
Publicado: (2018)

Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report
por: Vij, Ridhima, et al.
Publicado: (2023)

Ketamine Use for Cancer and Chronic Pain Management
por: Culp, Clayton, et al.
Publicado: (2021)

Sustained Loss of Bdnf Affects Peripheral but Not Central Vestibular Targets
por: Elliott, Karen L., et al.
Publicado: (2021)

Antidepressant mechanism of ketamine: perspective from preclinical studies
por: Scheuing, Lisa, et al.
Publicado: (2015)

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
por: Xu, Songbai, et al.
Publicado: (2022)

Effect of acupuncture on BDNF signaling pathways in several nervous system diseases
por: Miao, Chenxin, et al.
Publicado: (2023)

Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis
por: Yang, Mi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mthq1jlsrd52d1t325huar6uv9